Treatment of adult acute lymphoblastic leukemia: phase II trials of an induction regimen including PEG-L-asparaginase [pegaspargase] with or without PIXY [milodistim] in previously untreated patients, followed by allogeneic bone marrow transplantation or further chemotherapy in first complete remission.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Folinic acid; Mercaptopurine; Methotrexate; Prednisone; Tioguanine; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 06 Mar 2015 Biomarkers information updated
- 15 Jun 2011 Primary endpoint is identified as reported by ClinicalTrials.gov.
- 12 Sep 2005 New trial record.